Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9185 |
High Similarity |
NPD249 |
Approved |
0.9185 |
High Similarity |
NPD250 |
Approved |
0.9051 |
High Similarity |
NPD186 |
Discovery |
0.9051 |
High Similarity |
NPD195 |
Approved |
0.8897 |
High Similarity |
NPD185 |
Approved |
0.8889 |
High Similarity |
NPD193 |
Suspended |
0.8794 |
High Similarity |
NPD283 |
Approved |
0.8786 |
High Similarity |
NPD548 |
Clinical (unspecified phase) |
0.8768 |
High Similarity |
NPD166 |
Approved |
0.8671 |
High Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.8671 |
High Similarity |
NPD242 |
Approved |
0.8671 |
High Similarity |
NPD3107 |
Discontinued |
0.8671 |
High Similarity |
NPD338 |
Approved |
0.8671 |
High Similarity |
NPD1369 |
Phase 2 |
0.8611 |
High Similarity |
NPD339 |
Approved |
0.8552 |
High Similarity |
NPD169 |
Phase 2 |
0.8493 |
Intermediate Similarity |
NPD2646 |
Discontinued |
0.8493 |
Intermediate Similarity |
NPD1732 |
Phase 3 |
0.8493 |
Intermediate Similarity |
NPD2624 |
Phase 2 |
0.8411 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.8358 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.8243 |
Intermediate Similarity |
NPD219 |
Phase 3 |
0.8243 |
Intermediate Similarity |
NPD217 |
Approved |
0.8243 |
Intermediate Similarity |
NPD220 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD216 |
Approved |
0.8243 |
Intermediate Similarity |
NPD546 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD218 |
Approved |
0.8163 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD214 |
Approved |
0.8141 |
Intermediate Similarity |
NPD5666 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.7987 |
Intermediate Similarity |
NPD1777 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1776 |
Approved |
0.7941 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7871 |
Intermediate Similarity |
NPD247 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD7988 |
Suspended |
0.775 |
Intermediate Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD516 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD4716 |
Approved |
0.7702 |
Intermediate Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD9632 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD7158 |
Phase 1 |
0.759 |
Intermediate Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD1692 |
Approved |
0.7564 |
Intermediate Similarity |
NPD3083 |
Approved |
0.7552 |
Intermediate Similarity |
NPD252 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD194 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD307 |
Approved |
0.7347 |
Intermediate Similarity |
NPD3696 |
Approved |
0.7347 |
Intermediate Similarity |
NPD3695 |
Approved |
0.7347 |
Intermediate Similarity |
NPD549 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2630 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD2632 |
Approved |
0.7279 |
Intermediate Similarity |
NPD9606 |
Approved |
0.7226 |
Intermediate Similarity |
NPD9607 |
Approved |
0.7161 |
Intermediate Similarity |
NPD536 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD231 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD171 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3708 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD4240 |
Approved |
0.7059 |
Intermediate Similarity |
NPD9374 |
Approved |
0.7037 |
Intermediate Similarity |
NPD9373 |
Approved |
0.702 |
Intermediate Similarity |
NPD582 |
Approved |
0.6993 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6972 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD1431 |
Approved |
0.6954 |
Remote Similarity |
NPD1430 |
Approved |
0.6939 |
Remote Similarity |
NPD1058 |
Discontinued |
0.6936 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6885 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6885 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6832 |
Remote Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD3085 |
Phase 1 |
0.6812 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.6811 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6803 |
Remote Similarity |
NPD282 |
Approved |
0.6772 |
Remote Similarity |
NPD3086 |
Phase 3 |
0.6767 |
Remote Similarity |
NPD8836 |
Approved |
0.6761 |
Remote Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.6755 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6735 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD281 |
Approved |
0.6667 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD798 |
Discontinued |
0.6625 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.6623 |
Remote Similarity |
NPD1121 |
Approved |
0.6623 |
Remote Similarity |
NPD1120 |
Approved |
0.66 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD1128 |
Approved |
0.6599 |
Remote Similarity |
NPD1127 |
Approved |
0.6582 |
Remote Similarity |
NPD775 |
Approved |
0.6566 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD353 |
Discontinued |
0.6531 |
Remote Similarity |
NPD515 |
Phase 1 |
0.6517 |
Remote Similarity |
NPD207 |
Discontinued |
0.6497 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.6475 |
Remote Similarity |
NPD9375 |
Discontinued |
0.6474 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.6458 |
Remote Similarity |
NPD9409 |
Discontinued |
0.6447 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.6447 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6429 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6423 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.6415 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.641 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6405 |
Remote Similarity |
NPD535 |
Approved |
0.6397 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD1368 |
Approved |
0.6333 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.631 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.631 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.631 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6276 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6259 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.6258 |
Remote Similarity |
NPD6112 |
Approved |
0.625 |
Remote Similarity |
NPD8833 |
Approved |
0.625 |
Remote Similarity |
NPD8831 |
Approved |
0.6224 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.619 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6174 |
Remote Similarity |
NPD78 |
Approved |
0.6174 |
Remote Similarity |
NPD9544 |
Approved |
0.6164 |
Remote Similarity |
NPD580 |
Discontinued |
0.6159 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD757 |
Phase 3 |
0.6096 |
Remote Similarity |
NPD578 |
Discontinued |
0.6096 |
Remote Similarity |
NPD9360 |
Approved |
0.6094 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6081 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.6062 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.6058 |
Remote Similarity |
NPD6840 |
Approved |
0.6058 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6053 |
Remote Similarity |
NPD1356 |
Approved |
0.6053 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.6053 |
Remote Similarity |
NPD1354 |
Approved |
0.6038 |
Remote Similarity |
NPD1118 |
Discontinued |
0.6025 |
Remote Similarity |
NPD9704 |
Approved |
0.6012 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD9291 |
Approved |
0.5897 |
Remote Similarity |
NPD796 |
Phase 2 |
0.5882 |
Remote Similarity |
NPD1085 |
Approved |
0.5882 |
Remote Similarity |
NPD1775 |
Approved |
0.5862 |
Remote Similarity |
NPD9358 |
Approved |
0.5862 |
Remote Similarity |
NPD9359 |
Approved |
0.5857 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.5855 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.5853 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.5847 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5847 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5843 |
Remote Similarity |
NPD4089 |
Clinical (unspecified phase) |
0.58 |
Remote Similarity |
NPD9290 |
Approved |
0.5784 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5784 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.5779 |
Remote Similarity |
NPD9366 |
Approved |
0.5772 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.575 |
Remote Similarity |
NPD9550 |
Approved |
0.575 |
Remote Similarity |
NPD9551 |
Approved |
0.5739 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.5724 |
Remote Similarity |
NPD4262 |
Discontinued |
0.5694 |
Remote Similarity |
NPD9416 |
Phase 3 |
0.5694 |
Remote Similarity |
NPD9417 |
Phase 3 |
0.5674 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.5664 |
Remote Similarity |
NPD9415 |
Clinical (unspecified phase) |
0.566 |
Remote Similarity |
NPD5627 |
Approved |
0.5659 |
Remote Similarity |
NPD534 |
Phase 2 |
0.5659 |
Remote Similarity |
NPD537 |
Phase 2 |
0.5659 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.5657 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.5657 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.5657 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.5657 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.5655 |
Remote Similarity |
NPD613 |
Phase 2 |
0.5629 |
Remote Similarity |
NPD9292 |
Approved |
0.5629 |
Remote Similarity |
NPD9288 |
Approved |
0.5629 |
Remote Similarity |
NPD9289 |
Approved |
0.5629 |
Remote Similarity |
NPD76 |
Approved |
0.5621 |
Remote Similarity |
NPD306 |
Approved |
0.5615 |
Remote Similarity |
NPD5757 |
Discontinued |
0.5613 |
Remote Similarity |
NPD4812 |
Phase 1 |
0.5607 |
Remote Similarity |
NPD5337 |
Phase 1 |
0.5607 |
Remote Similarity |
NPD5336 |
Phase 1 |
0.5606 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.5605
|
Remote Similarity |
NPD9571 |
Approved |